Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Adams

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
BMJ Open|September 30, 2022
Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra studyAmeeta Retzer, Stephanie Sivell, Hannah Scott, et al.
JAMA Oncology|September 8, 2017
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical TrialMartin Scurr, Tom Pembroke, Anja Bloom, et al.
Neuro-Oncology Advances|September 18, 2023
Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods studyAmeeta Retzer, Elin Baddeley, Stephanie Sivell, et al.
BMJ Open|February 20, 2014
CRIB--the use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial (RCT) with embedded feasibility studyJulie Munro, Richard Adams, Anna Campbell, et al.
The Journal of Pathology|February 8, 2018
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsiesMatthew Alderdice, Susan D Richman, Simon Gollins, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 30, 2023
Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trialVicky Coyle, Caroline Forde, Danny F McAuley, et al.
Clinical Trials (London, England)|January 27, 2022
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancerLouise C Brown, Janet Graham, David Fisher, et al.
British Journal of Cancer|July 13, 2021
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backboneSanne Ten Hoorn, Dirkje W Sommeijer, Faye Elliott, et al.
Developmental Medicine and Child Neurology|November 17, 2022
Education and employment as young adults living with spina bifida transition to adulthood in the USA: A study of the National Spina Bifida Patient RegistryTiebin Liu, Lijing Ouyang, William O Walker, et al.
Cancer Treatment Reviews|June 15, 2021
Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysisRichard Adams, Kaitlyn Goey, Benoist Chibaudel, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
BMJ Open|September 30, 2022
Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra studyAmeeta Retzer, Stephanie Sivell, Hannah Scott, et al.
JAMA Oncology|September 8, 2017
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical TrialMartin Scurr, Tom Pembroke, Anja Bloom, et al.
Neuro-Oncology Advances|September 18, 2023
Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods studyAmeeta Retzer, Elin Baddeley, Stephanie Sivell, et al.
BMJ Open|February 20, 2014
CRIB--the use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial (RCT) with embedded feasibility studyJulie Munro, Richard Adams, Anna Campbell, et al.
The Journal of Pathology|February 8, 2018
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsiesMatthew Alderdice, Susan D Richman, Simon Gollins, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 30, 2023
Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trialVicky Coyle, Caroline Forde, Danny F McAuley, et al.
Clinical Trials (London, England)|January 27, 2022
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancerLouise C Brown, Janet Graham, David Fisher, et al.
British Journal of Cancer|July 13, 2021
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backboneSanne Ten Hoorn, Dirkje W Sommeijer, Faye Elliott, et al.
Developmental Medicine and Child Neurology|November 17, 2022
Education and employment as young adults living with spina bifida transition to adulthood in the USA: A study of the National Spina Bifida Patient RegistryTiebin Liu, Lijing Ouyang, William O Walker, et al.
Cancer Treatment Reviews|June 15, 2021
Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysisRichard Adams, Kaitlyn Goey, Benoist Chibaudel, et al.
Pageof 15